A CRISPR/dCasX-mediated transcriptional programming system for inhibiting the progression of bladder cancer cells by repressing c-MYC or activating TP53.
Congcong CaoLin YaoAolin LiQuan ZhangZhenan ZhangXiaofei WangYing GanYuchen LiuQian ZhangPublished in: Clinical and translational medicine (2022)